TNNT2 and chronic obstructive pulmonary disease: Mortality, however, was only marginally different between patients who did and did not have cTnT sampled.[10] This illustrates the difficulty in distinguising between COPD patients with higher and lower risks of myocardial damage in clinical practice, and indirectly supports the external validity of the present results.